Sumitomo Dainippon Pharma Co., Ltd. has installed the GigaSort® Platform in their newly opened Manufacturing Plant for Regenerative Medicine & Cell Therapy in Osaka, Japan. The center is the world’s first commercial iPSC plant. The GigaSort platform is a microfluidic based cell sorting technology that allows the selection of highly specific and pure cell populations in a manufacturing environment. “We are thrilled to be providing the GigaSort technology to Sumitomo Dainippon Pharma Co., Ltd. to enable exciting advances in regenerative…